Momentum Bioscience

Momentum bioscience

Momentum Bioscience is focused on developing rapid tests for patients suspected of sepsis. Our patented ETGA® technology allows the universal detection of viable organisms in normally sterile samples such as blood. This is now incorporated into MagRapid, a 2hr test that determines presence /absence of viable organisms together with Gram category from 5mL whole blood. With a limit of detection of <5 CFU/mL, MagRapid will be able to provide clinically actionable results earlier than blood culture. MagRapid is designed to be run on instruments already established in the clinical laboratory and Momentum is seeking partners for joint commercialisation.


Contact Information:


10 Fenlock Court,

Blenheim Office Park,

Long Hanborough,


OX29 8LN


Tel:      +44 (0)2921 677 910